![]() Post-IVT care, and IVT toxicity assessment. (eg, estimated average patient wait times), injection patterns, pre-IVT care and Questions assessed participants’ overall practice settings, injection practice trends Respondents were given the opportunity to win one of five $100 gift cards. A reminder email was sent to all retina specialists 1 week later. The survey was sent via email toġ677 retina specialists in the American Society of Retina Specialists network onĪpril 4, 2018. University of Michigan Institutional Review Board. Using the University of Michigan Qualtrics interface. We constructed an online, 31-question, multiple choice survey (Supplemental Material) Increasing strains from the rising volume of IVT. Patterns to see whether there were trends that may prove useful as the field faces ![]() The goal of this survey was to obtain data on existing practice Several aspects of the IVT process to date, we performed a survey among retina In light of the variability of IVT delivery practice patterns and the lack of data on Variability is common even among retina specialists in the same practice. 7 - 16 Practice patterns are often determined by regional convention, medicalĮxperience, and/or financial necessity. Practice patterns have demonstrated considerable variation both globally and regionally. Hampered the adoption of a single practice pattern for IVT, and surveys of IVT Mask, use of sterile gloves, type of anesthetics, and use of an eyelid speculum-has (office, treatment room, or operating room), use of topical antibiotics, use of a The lack of level 1 evidence-including the injection setting United States alone, 6 and this number continues to increase because of the aging population,Įxpanding indications for anti-VEGF therapy, and the obesity and diabetesĭespite the fast growth in IVT volume, the process of delivering IVT has notĭramatically changed. Based on a conservativeĮstimate, more than 6 million intravitreal injections were given in 2016 in the Of the most commonly performed procedures in ophthalmology. 1 - 5 The success of this therapy has made intravitreal injection therapy (IVT) one More in 25% to 41% of patients treated with intravitreal anti-VEGF. Prevention of vision loss but also substantial visual acuity gains by 15 letters or Macular edema, and retinal vein occlusion. Transformed the treatment landscape of exudative macular degeneration, diabetic Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy has
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |